These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3429589)

  • 1. Simple method for determination of flunarizine in serum by gas chromatography.
    Yamaji A; Kataoka K; Oishi M; Kanamori N; Tagawa T; Mimaki T
    J Chromatogr; 1987 Oct; 421(2):372-6. PubMed ID: 3429589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of flunarizine in serum by high performance liquid chromatography and its clinical application].
    Kataoka K; Kanamori N; Oishi M; Arakawa Y; Yamaji A; Tagawa T; Mimaki T; Yabuuchi H
    Yakugaku Zasshi; 1988 Mar; 108(3):226-31. PubMed ID: 3404406
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated capillary gas chromatographic determination of flunarizine.
    Kapetanovic IM; Torchin CD; Yonekawa WD; Kupferberg HJ
    J Chromatogr; 1986 Nov; 383(1):223-8. PubMed ID: 3818840
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay of flunarizine, (E)-1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine, in plasma of epileptic patients.
    Torchin CD; Kapetanovic IM; Yonekawa WD; Kupferberg HJ
    J Chromatogr; 1988 Apr; 426(2):444-8. PubMed ID: 3392157
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro plasma protein binding determination of flunarizine using equilibrium dialysis and liquid chromatography-tandem mass spectrometry.
    Lin ZJ; Musiano D; Abbot A; Shum L
    J Pharm Biomed Anal; 2005 Apr; 37(4):757-62. PubMed ID: 15797798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay of flunarizine in plasma and its application to biopharmaceutic investigations.
    Nieder M; Jaeger H
    J Chromatogr; 1986 Aug; 380(2):443-9. PubMed ID: 3760075
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic profile of topical flunarizine in rabbit eye and plasma.
    Maltese A; Bucolo C
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):171-9. PubMed ID: 12804062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of a calcium antagonist (PU 122) in plasma by gas chromatography.
    Marzo A; Treffner E; Meroni G; Ripamonti M; Pelloso R; Lucarelli C
    J Chromatogr; 1989 Dec; 497():296-301. PubMed ID: 2625466
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitive gas chromatographic method for the determination of cinnarizine and flunarizine in biological samples.
    Woestenborghs R; Michielsen L; Lorreyne W; Heykants J
    J Chromatogr; 1982 Oct; 232(1):85-91. PubMed ID: 7142341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial.
    Pledger GW; Sackellares JC; Treiman DM; Pellock JM; Wright FS; Mikati M; Sahlroot JT; Tsay JY; Drake ME; Olson L
    Neurology; 1994 Oct; 44(10):1830-6. PubMed ID: 7936231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the calcium antagonist flunarizine in biological fluids by gas-liquid chromatography.
    Flor SC
    J Chromatogr; 1983 Feb; 272(2):315-23. PubMed ID: 6833428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.
    Todd PA; Benfield P
    Drugs; 1989 Oct; 38(4):481-99. PubMed ID: 2684591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Determination of phenprocoumon (Marcumar R) by gas-liquid-chromatography.
    Schüppel RV; König R; Steinhilber E; Deckert FW
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R87. PubMed ID: 4276643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics and pharmacodynamics of flunarizine in multimorbid, geriatric patients with vertigo].
    Rolzhäuser HP; Oestreich W; Seiler KU; Peters T; Platt D; Jorisch D
    Arzneimittelforschung; 1991 Feb; 41(2):109-14. PubMed ID: 2043170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLC determination of chlorphenesin carbamate in serum.
    Kaiser DG; Shaw SR
    J Pharm Sci; 1974 Jul; 63(7):1094-7. PubMed ID: 4852199
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical treatment of epilepsy with calcium entry blockers.
    Overweg J; Binnie CD
    Funct Neurol; 1986; 1(4):539-41. PubMed ID: 3609880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of flunarizine in pediatric epilepsy.
    Cavazzuti GB; Galli V; Benatti A
    Funct Neurol; 1986; 1(4):551-4. PubMed ID: 3609882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic profile of flunarizine in animal models.
    Tort AB; Dall'Igna OP; de Oliveira RV; Mantese CE; Fett P; Gomes MW; Schuh J; Souza DO; Lara DR
    Psychopharmacology (Berl); 2005 Jan; 177(3):344-8. PubMed ID: 15290004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved direct injection method and extractive methylation method for determination of valproic acid in serum by gas chromatography.
    Nishioka R; Takeuchi M; Kawai S; Nakamura M; Kondo K
    J Chromatogr; 1985 Jul; 342(1):89-96. PubMed ID: 3930549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of flunarizine therapy on intractable epilepsy.
    Nakane Y; Seino M; Yagi K; Kaji S; Yamauchi T
    Arzneimittelforschung; 1989 Jul; 39(7):793-8. PubMed ID: 2675853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.